Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide-Reference-Cited by-同舟云学术

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

Published:2015-04 Issue:4 Volume:100 Page:1689-1698
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Bengtsson Daniel,Schrøder Henrik Daa,Andersen Marianne,Maiter Dominique,Berinder Katarina,Feldt Rasmussen Ulla,Rasmussen Åse Krogh,Johannsson Gudmundur,Hoybye Charlotte,van der Lely Aart Jan,Petersson Maria,Ragnarsson Oskar,Burman Pia

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors;Brain Pathology;2024-09

2. Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex;Journal of Medicinal Chemistry;2024-07-30

3. Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes;Current Oncology;2024-07-12

4. Characteristics and treatment of a silent somatotroph tumor that had transformed to a functional type: a case report and literature review;Gland Surgery;2024-07

5. Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients;Minerva Endocrinology;2024-07